InnovAge Holding Corp
NASDAQ:INNV
Relative Value
The Relative Value of one
INNV
stock under the Base Case scenario is
7.75
USD.
Compared to the current market price of 9.3 USD,
InnovAge Holding Corp
is
Overvalued by 17%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
INNV Competitors Multiples
InnovAge Holding Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
InnovAge Holding Corp
NASDAQ:INNV
|
1.3B USD | 1.4 | 194.9 | 36.1 | 82.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
101.2B USD | 0.3 | 57.2 | 14.4 | 14.4 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
64.9B EUR | 0.3 | 12.4 | 7.9 | 10.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
77.2B USD | 0.3 | 12.6 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
28.8B EUR | 1.3 | 26.1 | 10.9 | 16.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.3B EUR | 1.3 | 34.4 | 10.2 | 21.9 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.7B USD | 1.7 | 27.2 | 12.9 | 18.7 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
23.4B USD | 2.1 | 23.6 | 12.9 | 17.4 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.4B EUR | 0.6 | 15.8 | 6.3 | 13.4 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.3B USD | 12.5 | -29.6 | -31.7 | -28.8 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.7B USD | 0.8 | 14.4 | 7.4 | 10.1 |